Tratamiento para Cinetosis Severa

Opciones Farmacológicas

• Los antihistamínicos tienen un efecto supresor sobre el centro emético central para aliviar las náuseas y vómitos asociados con el mareo por movimiento, según la American Academy of Otolaryngology-Head and Neck Surgery 1, 2
• Los medicamentos anticolinérgicos como la escopolamina bloquean la acetilcolina, que es un neurotransmisor ampliamente distribuido en el SNC, y ayudan con el mareo por movimiento reduciendo el desajuste neural, según la American Academy of Otolaryngology-Head and Neck Surgery 1, 2
• La prometazina, que es una fenotiazina con propiedades antihistamínicas, también se usa comúnmente para el mareo por movimiento, según la American Academy of Otolaryngology-Head and Neck Surgery 1, 2

Limitaciones y Efectos Adversos

• Los medicamentos supresores vestibulares no se recomiendan para el tratamiento a largo plazo, ya que pueden interferir con la compensación central en condiciones vestibulares periféricas, según la American Academy of Otolaryngology-Head and Neck Surgery 1, 2
• Los medicamentos anticolinérgicos son un factor de riesgo independiente significativo para caídas, especialmente en pacientes ancianos, según Praxis Medical Insights 3

Motion Sickness Prevention and Treatment

Medication Options

• Meclizine is an antihistamine commonly used for motion sickness at doses of 12.5-25 mg three times daily, as recommended by the American Gastroenterological Association 4
• Promethazine is a phenothiazine with antihistamine properties used for motion sickness, with a usual dose of 12.5 to 25 mg, and has been found to have side effects including hypotension, respiratory depression, neuroleptic malignant syndrome, and extrapyramidal effects, according to the American Gastroenterological Association 5

Dosage and Administration

• The American Gastroenterological Association recommends meclizine 12.5-25 mg three times daily for patients who cannot use scopolamine due to contraindications or side effects 4
• Promethazine 12.5-25 mg is recommended for severe cases where rapid onset is needed, as suggested by the American Gastroenterological Association 5

Managing Motion Sickness with Scopolamine and Meclizine

Introduction to Combination Therapy

• The American Gastroenterological Association recommends using scopolamine transdermal patch and meclizine together for motion sickness when severe symptoms require combination therapy, providing complementary mechanisms of action 6

Dosing and Administration

• The Clinical Gastroenterology and Hepatology guidelines suggest applying a 1.5 mg scopolamine transdermal patch behind the ear at least 6-8 hours before anti-motion sickness effect is needed, with each patch lasting approximately 3 days 6
• Meclizine dosing is recommended at 12.5-25 mg three times daily as needed, according to the Clinical Gastroenterology and Hepatology guidelines 7

Special Populations

• The American Society of Anesthesiologists notes that elderly patients are at higher risk for anticholinergic side effects and should be monitored closely when using scopolamine and meclizine 8

Motion Sickness Prevention and Treatment

Mechanism and Efficacy

• Scopolamine works as an anticholinergic agent by blocking acetylcholine, a widespread CNS neurotransmitter, reducing neural mismatch that causes motion sickness, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 9
• Meclizine works by suppressing the central emetic center to relieve nausea and vomiting, with a probable effectiveness of 40% prevention under natural conditions, as stated by the American Academy of Otolaryngology-Head and Neck Surgery 9

Special Populations

• The American Academy of Pediatrics and other medical societies may have guidelines for breastfeeding, and scopolamine passes into breast milk, so consideration should be given to interrupting breastfeeding or selecting alternative medication, according to the Infectious Diseases Society of America 10

Common Pitfalls to Avoid

• Long-term use of antihistamines or benzodiazepines interferes with natural vestibular compensation and adaptation, as warned by the American Academy of Otolaryngology-Head and Neck Surgery 9

Prevention and Treatment of Motion Sickness

Medication Selection

• The American Academy of Otolaryngology-Head and Neck Surgery recommends avoiding vestibular suppressant medications such as benzodiazepines for motion sickness due to lack of efficacy and significant harm potential 11

Motion Sickness Management with Meclizine and Ondansetron

Medication Dosage and Administration

• The American Gastroenterological Association recommends ondansetron 8 mg every 4-6 hours during episodes for motion sickness management, with a sublingual formulation preferred 12
• A baseline ECG is recommended before starting ondansetron due to the risk of QTc prolongation, as suggested by the Gastroenterology society 12

Alternative Treatment Options

• For severe cases requiring rapid onset, promethazine 12.5-25 mg can be used, although it has more side effects, including sedation and extrapyramidal symptoms, according to the Gastroenterology guidelines 12

Safety Considerations for Anticholinergic Use in Motion Sickness

Elderly Patients

• Initiating scopolamine or meclizine at reduced doses and titrating cautiously in older adults lowers the risk of anticholinergic adverse events such as falls and cognitive impairment. 13
• Anticholinergic medications are an independent risk factor for falls in the elderly; clinicians should monitor closely and preferentially avoid high‑potency agents when possible. 13
• Prescribing multiple anticholinergic agents concurrently to older patients should be avoided because the cumulative anticholinergic burden markedly increases fall risk. 13

Patients with Anticholinergic Sensitivity

• Scopolamine should be omitted entirely in individuals with glaucoma, urinary retention, or severe prostatic hypertrophy due to the risk of exacerbating these conditions. 14
• Concomitant use of over‑the‑counter decongestants, cold/flu remedies, allergy medications, sleep aids, or psychoactive drugs that possess anticholinergic properties can compound side‑effects and should be reviewed before prescribing scopolamine or meclizine. 14

Ocular Adverse Effects of Scopolamine

• Rare ocular events such as postoperative glare or diplopia have been reported with the use of scopolamine transdermal patches. 14

Pharmacologic Management of Motion Sickness in Special Populations (cited evidence)

Adolescents (ages 12‑17)

• In adolescents, meclizine or scopolamine can be administered using the same dosing regimen as in adults for motion‑sickness prevention (e.g., oral meclizine 12.5‑25 mg or a 1.5 mg scopolamine patch applied 6‑8 h before travel)【15】
• Domperidone may be used to treat nausea associated with motion sickness in adolescents【15】

Pregnant Individuals

• Acetaminophen (paracetamol) is recommended as the first‑line medication for motion‑sickness prevention in pregnancy, despite its modest efficacy【16】
• Metoclopramide can be employed to relieve nausea related to motion sickness during pregnancy【16】
• Scopolamine and antihistamines should be avoided in pregnancy unless the expected therapeutic benefit clearly outweighs potential fetal risks【16】

Breastfeeding Individuals

• Ibuprofen is regarded as safe for use in breastfeeding patients when managing motion‑sickness symptoms【16】